4.7 Article

Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition

期刊

NEUROLOGY
卷 78, 期 7, 页码 477-484

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e318246d67a

关键词

-

资金

  1. Commonwealth Scientific Industrial Research Organization through the Australian Imaging, Biomarkers and Lifestyle flagship study of aging
  2. Austin Hospital Medical Research Foundation
  3. Neurosciences Victoria
  4. University of Melbourne
  5. CSIRO
  6. Janssen
  7. Lundbeck Inc.
  8. Pfizer Inc
  9. Eli Lilly and Company
  10. GlaxoSmithKline
  11. Forest Laboratories, Inc.
  12. Novartis
  13. Bayer Schering Pharma
  14. Avid Radiopharmaceuticals, Inc.
  15. Alzheimer's Association
  16. Alzheimer's Drug Discovery Foundation

向作者/读者索取更多资源

Objective: Given the recent and growing interest in the concepts of prodromal and presymptomatic Alzheimer disease, it is crucial to determine whether the presence of beta-amyloid (A beta) in the brain of asymptomatic elderly individuals is a pathologic condition associated with accelerated neuronal and synaptic loss. The aim of the present study was to assess whether A beta influences the rate of atrophy in cognitively normal elderly individuals. Methods: Seventy-four healthy elderly individuals underwent an MRI scan and a C-11-Pittsburgh compound B (PiB) PET scan at baseline and a second MRI scan 18 months later. Voxel-wise analyses were performed using maps of annual rate of atrophy generated from the serial MRI scans, including comparison between individuals with high vs low neocortical PiB and correlation with baseline neocortical PiB. Results: The rate of atrophy was significantly higher in the normal elderly individuals with high PiB compared with those with low PiB and was significantly correlated with baseline neocortical PiB, with the highest significance in the temporal neocortex and the posterior cingulate cortex. Conclusions: Our findings show that the presence of A beta in the brain, known to occur in about one-third of asymptomatic elderly individuals, is actually a pathologic state associated with accelerated atrophy. They also suggest that therapy aimed to reduce the neurodegenerative process should be commenced in presymptomatic individuals with high PiB. Neurology (R) 2012;78:477-484

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据